Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report) was down 1% during mid-day trading on Friday . The stock traded as low as $44.46 and last traded at $44.62. Approximately 23,381 shares traded hands during trading, a decline of 31% from the average daily volume of 33,707 shares. The stock had previously closed at $45.06.
Wall Street Analyst Weigh In
Separately, BNP Paribas lowered Sandoz Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 2nd.
Read Our Latest Stock Report on Sandoz Group
Sandoz Group Trading Down 1.0 %
About Sandoz Group
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Read More
- Five stocks we like better than Sandoz Group
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Oilfield Leader SLB: An AI Name You Need to Know
- 3 Warren Buffett Stocks to Buy Now
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
